Personal history

Home Address: 24721 Laurel Ridge Drive

Malibu, California 90265

Home Phone: 310.963.0009

Office Address: UCLA Integrated Substance Abuse Programs

University of California, Los Angeles

11075 Santa Monica Blvd, Suite 200

Los Angeles, California 90025

Office Phone: 310.267.5535

E-mail: dfarabee@ucla.edu

Date of Birth: July 16, 1963; Dallas, Texas

Citizenship: United States

1985 University of Texas, Austin B.A., Psychology

1988 Texas A&M University, Commerce M.S., Psychology

1992 Texas Christian University Ph.D., Experimental Psychology

2008-present Professor-in-Residence. UCLA Department of Psychiatry & Biobehavioral Sciences.

2005-2008 Research Psychologist at the University of California at Los Angeles Integrated Substance Abuse Programs (ISAP).

2000-2004 Associate Research Psychologist at the University of California at Los Angeles Integrated Substance Abuse Programs (ISAP).

1997-1999 Assistant Research Psychologist at the University of California at Los Angeles Integrated Substance Abuse Programs (ISAP).

1995-1997 Assistant Professor of Psychiatry and Research Scientist at the Center on Drug and Alcohol Research at the University of Kentucky.

1993-1995 Lead Analyst, Texas Commission on Alcohol and Drug Abuse.

1989-1992 Research Assistant, Institute of Behavioral Research, Texas Christian University.

2004-present American Psychological Association

1997-present American Society of Criminolgy

Community Activities

Advisor to the Africa Mental Health Foundation (AMHF) in the area of alcohol and substance abuse (www.africamentalhealthfoundation.org).

Member of the County of Los Angeles Department of Mental Health Adult Systems of Care—Jail Mental Services, Quality, Academics and Research Advisory Board.

Member of the U.S. Health and Human Services Advisory Committee on HIV and STD Prevention of the Centers for Disease Control (2002-2005).

Co-Editor of the Offender Programs Report (New York: Civic Research Institute)

Visiting professor at the Universidad Autonoma de Nuevo Leon in Monterrey, Mexico (2001-present)

Member of the UCLA Institutional Review Board (2006-2009)

Consulting Activity

2006 Statistical analysis and report preparation (for Northrop Grumman) to for the national Opioid Treatment Program Accreditation Evaluation, funded by SAMHSA.

2004-present Evaluator for Dallas site of the CSAT-funded Treatment Capacity Expansion project.

2001 Conducted a recidivism study comparing public and private prison releases in the State of Florida, funded by the Florida Correctional Privatization Commission.

2000. 
      Policy analyst for the Texas Comptroller Office. Provided recommendations for improving the treatment system operated by the Texas Department of Criminal Justice.
      

1996 Evaluated the effectiveness of alternative criminal justice sanctions used in northern Kentucky. Study funded by the Northern Kentucky Corrections Advisory Board.

1995 Technical Merit Reviewer for Center for Substance Abuse Treatment RFP: Criminal Justice Treatment Network. Washington, D.C.

Editorial Services

Reviewer for Addiction, Crime & Delinquency, Criminology and Public Policy, Drug and Alcohol Dependence, Criminal Justice and Behavior, & Journal of Substance Abuse Treatment. Editor of the Offender Programs Report.

HONORS

1 U01 DA034743-01A1 (PI: Farabee) 06/01/13 - 05/31/17

NIH/NIDA $422,062
The major goal of this project is to assess two recently developed depot pharmacotherapies for opiate dependence—Vivitrol and Probuphine, with regard to patient acceptance, effectiveness, and economic benefits.
Evaluation of the Integrated Services for Mentally Ill Parolees (ISMIP) and Case Management Reentry Pilot (CMRP) Programs

Contract No.5600005097 (PI: Farabee)

California Department of Corrections and Rehabilitation 01/01/15-12/31/16 2016
This project involves a process and outcome evaluation of the ISMIP and CMRP programs. The process evaluation is devoted to describing how these programs actually function, and to what extent eligible parolees participate in the available services. The outcome evaluation will focus on arrests, convictions, and time to first arrest for program referrals compared to matched comparison subjects drawn from concurrent release samples.

Completed

Enhancing Follow-up Rates Through a Rechargeable Incentive Card (RIC) System

2 R42 DA025387 (PI: Farabee) 05/01/12 - 01/31/14

NIH/NIDA/Calance Corporation $335,020
The major goal of this Phase II Small Business Technology Transfer (STTR) project is to conduct a randomized field test of the rechargeable incentive card (RIC) system developed in Phase I, and to execute a detailed plan to commercialize the finalized set of products and services for the purpose of improving validity and generalizability of longitudinal substance abuse research and follow-up rates.
An Experimental Comparison of Telepsychiatry and Conventional Psychiatry for Mentally Ill Parolees

2010-90983-CA-IJ (PI: Farabee) 10/01/10-06/30/15

National Institute of Justice/U.S. DOJ $608,248
The major goal of this project is to evaluate the effectiveness of telepsychiatry for parolees relative to conventional face-to-face sessions. Outcomes include therapeutic alliance, medication adherence, clinic attendance, psychological functioning, and recidivism.
It Came from the North: Estimating the Production of Synthetic Drugs in Quebec, Canada

2010-94019-CA-IJ (PI: Farabee) 01/01/11-12/31/14

National Institute of Justice/U.S. DOJ $367,845
The major goal of this project is to estimate the size of synthetic drug production (methamphetamine in particular) in Quebec, Canada, assess its export potential, and explore implications for counter-narcotics policies.

The Pacific Coast Research Center Of the NIDA CJ-DATS

5 U01 DA16211-03 (Co-PI: Farabee) 09/30/02 - 09/01/13

NIH/NIDA $3,265,000

The major goal of this project is to collaborate with other CJ-DATS Research Centers in developing and evaluating system-level interventions for drug abusing offenders in prison and on parole.

C08.145 (PI: Farabee) 11/1/08—10/31/11

State of California/CDCR $268,584
In accordance with the California Logic Model, to insure a continuum of care, the Division of Adult Parole Operations (DAPO) is utilizing contracted benefits social workers (BSW) within the prisons to apply for federal and state benefit entitlements prior to an inmate’s return to the community. Benefits that will be applied for are: SSA benefits, State sponsored Medi-Cal, and VA benefits. In accordance to Provision 22: Reducing Recidivism, the purpose of this evaluation is to provide CDCR Executive Staff and the California State Legislature with information about the effectiveness of the P3 Benefits Program.
A Randomized Controlled Trial of the Second Chance Program for Ex-Inmates

2008-7752 (PI: Farabee) 09/01/08 - 09/01/11

Smith Richardson Foundation $345,435
The major goal of this project was to conduct a process and outcome evaluation and a cost analysis of the Second Chance’s PREP program.

Four Models of Telephone Support for Stimulant Recovery

1 R01 DA18208 (PI: Farabee) 04/01/05 - 03/31/11 NIH/NIDA $2,627,680

The major goal of this project wais to compare the efficacy of four low-cost, telephone support protocols for patients who have completed the intensive phase of a structured, outpatient stimulant abuse treatment program.
Enhancing Follow-up Rates Through a Rechargeable Incentive Card (RIC)

1 R41 DA025387-01 (Farabee) 07/01/08 - 3/31/11

Calance Corp/NIH/NIDA $35,097

System
The major goal of this project was to develop a national network that supports a rechargeable incentive card (RIC) system designed to enhance follow-up rates and to assess the feasibility and commercial potential of the system.

C06.417 (PI: Farabee) 01/01/07 – 12/31/09

State of California/CDC $300,000

The purpose of this project was to assess the predictive validity of a risk assessment tool (COMPAS) recently adopted by the California Department of Corrections. Our study evaluated the extent to which this instrument can correctly classify offenders who pose the greatest risks upon release.

5 R01 DA15431-03 (PI: Hser; Co-PI: Farabee) 07/20/02 - 06/30/06

NIH/NIDA $3,397,381

The major goal of this project was to examine the treatment system impact and outcomes of Proposition 36 in five selected counties and to explore the effects of the implementation of Proposition 36 on California’s treatment delivery system, the system’s response, and the relationships between the treatment system and the criminal justice system.

P02.0016 (PI: Farabee) 7/02 - 6/08

State of California/CDC $750,000

The major goal of this project was to evaluate the Mental Health Services Continuum Program (MHSCP) with respect to how well the in-prison and community-based components were planned, developed, and implemented, and to what extent do activities and services achieved the program’s goals and objectives.

Contract No. 98.346 (PI: Prendergast; Co-PI: Farabee) 7/99-6/04

California Department of Corrections $3,750,552

The purpose of this project was to conduct process and outcome evaluations of six prison-based therapeutic community treatment programs funded by the California Department of Corrections. The project also included examination of special topics related to prison-based treatment programs that are of interest to the Department.

99-CE-VX-0003 (PI: Farabee) 1/00-6/02

National Institute of Justice $300,000

This study was designed to accomplish five primary goals: (1) assess the rates of antipsychotic medication adherence among severely mentally ill parolees, (2) validate the use of hair assays as a means for assessing medication compliance, (3) compare medication adherence of mentally ill (non-substance dependent) and comorbid parolees, (4) identify reasons for adherence/non-adherence (according to clinical staff and parolees), and (5) measure the extent to which medication adherence is associated with various parolee outcomes such as violent behavior, return to custody, and psychosocial functioning.

Contract No. 822-103 (PI: Farabee) 7/98-8/01

California Youth Authority $426,256

The purpose of the evaluation was to determine the extent to which program components are being implemented and to identify factors that either impede or enhance the delivery of program services. Funded by the Office of Criminal Justice Planning, the CYA-RSAT programs are currently operating at nine institutional sites across the state.

1992 Lehman, W.E.K., Farabee, D., Holcom, M.L., & Simpson, D.D. Prediction of substance use: Unique contributions of personal and job environment factors. Paper presented at the meeting of the Society for Industrial Organizational Psychologists, Montreal, Canada.

1994 Crouch, B., Dyer, J., Farabee, D., Gorton, J., & Bodiford, C. Field problems in collecting self-report, urine and hair data on offenders' substance use. Paper presented at the meeting of the American Society of Criminology, Miami, FL.

1995 Wallisch, L. and Farabee, D. Gambling and problem gambling among women in Texas prisons. Paper presented at the meeting of the Ninth National Conference on Gambling Behavior, San Juan, Puerto Rico.

1995 Farabee, D., McClellan, D., & Crouch, B. Early victimization, drug use, and criminality: A comparison of male and female prisoners. Poster session presented at the meeting of the Academy of Criminal Justice Sciences, Boston, MA.

1996 Leukefeld, C.G. and Farabee, D. Mandatory treatment, HIV, and injecting drug users. Invited paper presented at the Spanish Interdisciplinary AIDS Society’s Third National Meeting on AIDS, Galicia, Spain.

1996 Farabee, D. and Leukefeld, C.G. Injection drug use and HIV seropositivity among incarcerated men and women in the United States. Invited paper presented at the Spanish Interdisciplinary AIDS Society’s Third National Meeting on AIDS, Galicia, Spain.

1996 Farabee, D., Leukefeld, C.G., Logan, T., Beaven, S., McKiernan, P., Woolley, S., Cavanaugh, B., Clayton, R., Parker, J., Peyton, B., Cantrill, J., Huffman, M., & McCoy, C. Substance abuse treatment availability by AIDS-risk severity. Paper presented at the 104th Annual Convention of the American Psychological Association, Toronto, Canada.

1996 Farabee, D., Leukefeld, C.G., & Logan, T.K. City size, city seroprevalence, and HIV risk behaviors among out-of-treatment drug users. Paper presented at the National Institute on Drug Abuse Symposium: Perspectives on Rural Substance Abuse, Ames, IA.

1996 Farabee, D., & McClellan, D.S. Perceptions of punishment: A comparison of male and female prisoners. Paper presented at the annual meeting of the Academy of Criminal Justice Sciences, Las Vegas, Nevada.

1997 Farabee, D. Criminal justice treatment: The U.S. experience. Invited paper presented at the Royal Society of Medicine’s conference “Drug Misusers: Whose Business is it?” London, England.

1997 Farabee, D., & Leukefeld, C.G. HIV risk among high-frequency arrestees. Paper presented at the Annual Meeting of the American Society of Criminology, November 17th, San Diego, California.

1997 Farabee, D., & Leukefeld, C.G. Self-assessed HIV risk and the efficacy of HIV prevention among street drug users. Poster presented at the 125^th Annual Meeting of the American Public Health Association, Indianopolis, Indiana.

1997 Farabee, D., & Leukefeld, C.G. Missed opportunities for AIDS prevention: Criminal justice and substance abuse treatment settings in a rural state. Paper presented at the 105^th Annual Convention of the American Psychological Association, Chicago, IL.

1997 Leukefeld, C.G., Farabee, D., Cottler, L., Desmond, D., Hoffman, J., Inciardi, J., & Wechsberg, W. A multisite study of real and perceived HIV risk by county population density. Paper presented at the 59^th Annual Scientific Meeting of the College on Problems of Drug Dependence, Nashville, TN.

1997 Hays, L., Farabee, D., & Miller, W. Caffeine and nicotine use in an addicted population. Poster presented at the Conference of the American Society of Addiction Medicine, San Diego, CA.

1998 Anglin, M.D., & Farabee, D. The role of coercion in offender drug treatment. Invited paper presented to the Physician Leadership on National Drug Policy, November 10, Washington, DC.

1998 Farabee, D., Prendergast, M.L., Cartier, J., & Anglin, M.D. Proximal outcomes from California’s largest in-prison therapeutic community. Paper presented at the Annual Meeting of the American Society of Criminology, November 12th, Washington, DC.

1998 Anglin, D.A. & Farabee, D. Coerced treatment of criminal offenders. Paper presented at the Annual Conference of the American Society of Addiction Medicine, New Orleans, LA.

2000 Farabee, D. , Prendergast, M.L., & Cartier, J. Psychosocial changes among special populations in a prison-based therapeutic community. Paper presented at the Annual Meeting of the American Society of Criminology, November 15th, San Francisco, CA.

2000 Farabee, D., Shen, H., Hser, Y.I., Grella, C., & Anglin, M.D. The effect of substance abuse treatment on adolescent criminality. Paper presented at the meeting of the Academy of Criminal Justice Sciences, New Orleans, LA.

2001 Farabee, D., & Sanchez, S. Substance abuse and medication adherence among mentally ill parolees. Poster presentation at the Annual Meeting of the American Psychological Association, August 24-28, 2001, San Fransico, CA.

2001 Farabee, D., & Sanchez, S. Measuring drug use and medication adherence among mentally ill parolees. Presented at the Annual Meeting of the American Society of Criminology, November 7-10, 2001, Atlanta, GA.

2001 Farabee, D., Prendergast, M.L., & Cartier, J. Methamphetamine use and HIV risk among substance-abusing offenders in california. Poster presented at the 63^rd Annual Scientific Meeting of the College on Problems of Drug Dependence, Scottsdale, AZ.

2002 Messina, N., Farabee, D., & Rawson, R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder. American Psychological Association, August 25, Chicago, Illinois.

2004 Farabee, D. The effectiveness of needle exchange programs. Invited paper presented at the Third Meeting of the World Health Organization’s Eastern Mediterranean Regional Advisory Panel, Cairo, Egypt.

2004 Farabee, D., Hser, Y.I., Anglin, M.D., & Huang, D. Recidivism among an early cohort of California’s Proposition 36 offenders. Presented at the Annual Meeting of the American Society of Criminology, November 17, 2004, Nashville, TN.

2005 Farabee, D., & Garner, B. Psychometrics of the Inmate Pre-Release Assessment (IPASS). Presented at the Annual Meeting of the American Society of Criminology, November 18, 2004, Toronto, Canada.

2006 Farabee, D. Is Treatment really the road to rehabilitation? Promoting offender change through accountability. Invited paper presented at the Semi-Annual Meeting of the National Research Council’s Committee on Law and Justice. Irvine, CA.

2007 Farabee, D. Evidence-based practices for offenders. Invited paper presented at the annual meeting of the Oregon District Attorneys’ Association. Bend, OR.

2007 Farabee, D. The Inmate Pre-Release Assessment (IPASS). Presented at the Annual Meeting of the College on Problems of Drug Dependence, June 20, 2007, Quebec City, Canada.

2007 D. Farabee, R. Rawson, M. Karno, V. Pearce, J. Brummer, S. Cousins, & S. Patel. Four models of telephone support for stimulant recovery. American Academy of Addiction Psychiatry, San Diego, California, 2007.

2008 Farabee, D. Effective interventions for addicted offenders. Invited presentation at the Holyrood Magazine conference, “Beyond McLeish: New Ideas, Lasting Solutions—Seeking Change in Scotland’s Sentencing Policy.” September 8, 2008. Edinburgh, Scotland.

2008 D. Farabee, R. Rawson, M. Karno, V. Pearce, A. Bellows, J. Hemberg, S. Cousins, & S. Patel. Continuing care for stimulant recovery: An experimental test of telephone support. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June 19, 2008. San Juan, Puerto Rico.

2009 D. Farabee. HIV and Corrections: An International Perspective. Invited presentation at the International Conference on Global Health. December 8, 2009. Taipei, Taiwan.

2009 D. Farabee & S. Zhang. Managing an on-the spot lottery in reentry services. Presented at the Annual Meeting of the American Society of Criminology, November 18, 2009, Philadelphia, PA.

2010 D. Farabee, Wright, B., & Zhang, S. What is the evidence for evidence- based offender programs? Presented at the Stockholm Criminology Symposium, June 15, 2010. Stockholm, Sweden.

2010 D. Farabee & S. Zhang. A critical examination of offender needs assessment: Are all those questions really necessary? Presented at the Annual Meeting of the American Society of Criminology, November 17, 2010, San Francisco, CA.

2011 D. Farabee, S. Zhang, & B. Wright. Impact of a reentry program on employment and recidivism: Results of a randomized field experiment. Presented at the Annual Meeting of the American Society of Criminology, November 18, 2011, Washington, D.C.

2012 D. Farabee & Zhang, S. Effect-size inflation of post-hoc versus intent-to treat analyses of experimental offender interventions. Presented at the Stockholm Criminology Symposium, June 13, 2012. Stockholm, Sweden.

2013 D. Farabee. Global epidemiology of amphetamine-type stimulants. Invited presentation at the International Conference on Addiction. March 6, 2013. Jazan, Saudi Arabia.
BIBLIOGRAPHY

Research Papers—Peer Reviewed

1993 Farabee, D., Holcom, M.L., Ramsey, S., & Cole, S. Social anxiety and speaker gaze in a persuasive atmosphere. Journal of Research in Personality, 27, 365-376.

1993 Farabee, D., Nelson, R., Spence, R. Psychosocial profiles of criminal justice- and non-criminal justice-referred clients in treatment. Criminal Justice and Behavior, 20, 336-346.

1995 Farabee, D., Simpson, D.D., Dansereau, D., & Knight, K. Cognitive inductions into treatment among drug users on probation. Journal of Drug Issues, 25, 669-682.

1995 Farabee, D., Wallisch, L.S., & Maxwell, J.C. Substance use among Texas Hispanics and non-Hispanics: Who's using, who's not, and why. Hispanic Journal of Behavioral Sciences, 17, 523-536.

1995 Lehman, W.E.K, Farabee, D., Holcom, M.L., & Simpson, D.D. Prediction of substance use in the workplace: Unique contributions of demographic and work environment variables. Journal of Drug Issues, 25, 253-274.

1996 Farabee, D., & Fredlund, E.V. Self-reported drug use among recently admitted jail inmates: Estimating prevalence and treatment needs. Substance Use and Misuse, 31, 423-435.

1997 Leukefeld, C.G, Gallego, M.A., & Farabee, D. Drugs, crime, and HIV. Substance Use and Misuse, 32(6), 749-756.

1997 Maxwell, J.C., Wallisch, L.S., Farabee D., & Spence, R.T. A model for assessing prevention needs. Journal of Primary Prevention, 17(3), 315-334 .

1997 McClellan, D., Farabee, D., & Crouch, B. Early victimization, drug use, and criminality: A comparison of male and female prisoners. Criminal Justice and Behavior, 24(4), 455-476.

1998 Logan, T.K., Leukefeld, C.G., & Farabee, D. Sexual and drug use behaviors among women crack users: Implications for prevention. AIDS Education and Prevention, 10 (4) 327-340.

1998. 
      Farabee, D., Leukefeld, C.G., & Hays, L.R. Accessing drug abuse treatment: Perceptions of out-of-treatment injectors. Journal of Drug Issues, 28(2), 381-394.
      

1998 Hays, L.R., Farabee, D., & Miller, W. Caffeine and nicotine use in an addicted population. Journal of Addictive Diseases, 17(1), 47-54.

1998 Leukefeld, C.G., Logan, T., Martin, S. Purvis, R.T., & Farabee, D. Health service utilization among drug -abusing offenders. American Behavioral Scientist, 41(8), 1122-1135.

1999 Farabee, D., Prendergast, M.L., Cartier, J., Wexler, W., Knight., K., & Anglin, M.D. Barriers to implementing effective correctional treatment programs. The Prison Journal, 79(2), 150-162.

1999. 
      Farabee, D., & Leukefeld, C.G. Opportunities for AIDS prevention in a rural state in criminal justice and substance abuse treatment settings.Substance Use and Misuse, 34 (4&5), 617-632.
      

1999 Leukefeld, C.G., Logan, T.K., Farabee, D., Watson, D., Spalding, H., & Purvis, R. Drug dependency and HIV testing among state prisoners. Population Research and Policy Review, 18, 55-69.

2001 Farabee, D., Joshi, V., & Anglin, M.D. Addiction careers and criminal specialization. Crime & Delinquency, 47(2), 196-220.

2001 Farabee, D., Shen, H., Hser, Y.I., Grella, C., & Anglin, M.D. The effect of substance abuse treatment on adolescent criminality. Journal of Adolescent Research, 16(6), 679-696.

2001 Hegamin, A.H., Anglin, G., & Farabee, D. Gender differences in the perception of drug treatment: Assessing drug treatment for youthful offenders. Substance Use and Misuse, 36, 2159-2170.

2001 Prendergast, M.L., Farabee, D., & Cartier, J. The impact of in-prison therapeutic community programs on prison management. Journal of Offender Rehabilitation, 32(3), 63-78.

2002 Burdon, W.M., Farabee, D., Prendergast, M.L., Messina, N.P., & Cartier, J. Prison-based therapeutic community programs: Implementation and operational issues. Federal Probation, 66(3), 3-8.

2002 Farabee, D. Editor of special issue: Making people change: The effectiveness of coerced psychological treatment. Criminal Justice and Behavior, 29(1).

2002 Farabee, D. Re-examining Martinson’s critique: A cautionary note for evaluators. Crime & Delinquency, 48(1), 189-192.

2002 Farabee, D., Prendergast, M.L., & Cartier, J. Methamphetamine use and HIV risk among substance-abusing offenders in California. Journal of Psychoactive Drugs, 34(3), 295-300. (PMID: 12422940)

2002 Farabee, D., Rawson, R.A., & McCann, M. Adoption of drug avoidance activities among patients in contingency management and cognitive-behavioral treatments. Journal of Substance Abuse Treatment, 23, 343-350. (PMID: 12495796)

2002 Farabee, D., Shen, H., & Sanchez, S. Perceived coercion and treatment need among mentally ill parolees. Criminal Justice and Behavior, 29(1), 76-86.

2002 Leukefeld CG, Logan TK, Farabee D, Clayton R., Drug use and AIDS: estimating injection prevalence in a rural state. Subst Use Misuse. 2002, 37(5-7), 767-782. (PMID: 12117069)

2002 Leukefeld, C.G., Farabee, D., McDermeit, M., Dennis, M.L., Wechsberg, W.M., Inciardi, J.A., Surratt, H.L., Compton, W.M., Cottler, L.B., Klein, H., Hoffman, J.A., Desmond, D., & Logan, T.K. Real and perceived HIV risk by population density. Journal of Drug Issues, 31(4), 889-900.

2002 Prendergast, M.L., Farabee, D., Cartier, J., & Henken, S. Coerced treatment within a prison setting: Impact on psychosocial change during treatment. Criminal Justice & Behavior, 29 (1), 5-26.

2002 Rawson, R.A, Huber, A., McCann, M., Shoptaw, S., Farabee, D., Reiber, C., & Ling, W. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry, 59, 817-824. (PMID: 12215081)

2003 Hegamin, A., & Farabee, D. RSAT programs for youngh offenders in California: A Descriptive Study. Journal of Offender Rehabilitation, 37, 123-138.

2003 Hser, Y.I., Teruya, C., Evans, E., Longshore, D., Grella, C., & Farabee, D. Treating drug-abusing offenders: Initial findings from a five-county study on the impact of California’s Proposition 36 on treatment system and patient outcomes. Evaluation Review, 27 (5),479-505. (PMID:14531316)

2003 Messina, N., Farabee, D., & Rawson, R. Treatment responsivity of cocaine-dependent patients with antisocial personality disorder in cognitive behavioral and contingency management interventions. Journal of Consulting and Clinical Psychology, 71(2), 320-329. (PMID: 12699026)

2004 Farabee, D., Hser, Y.H., Anglin, M.D., & Huang, D. Recidivism among an early cohort of California’s Proposition 36 offenders. Criminology & Public Policy, 3(4), 501-522.

2004 Farabee, D., Shen, H., & Sanchez, S. Program-level predictors of antipsychotic medication adherence among parolees. International Journal of Offender Therapy and Comparative Criminology, 48(5), 561- 571. (PMID: 15358931)

2004 Farabee, D., & Shen, H. Antipsychotic medication adherence, cocaine use, and recidivism among a parolee sample.Behavioral Sciences and the Law, 22, 467-476. (PMID: 15282835)

2004 Prendergast, M.L., Campos, M., Farabee, D., Evans, W., & Martinez, J. Reducing substance use in prison: The California Department of Corrections Drug Reduction Strategy Project. The Prison Journal, 84 (2), 265-280.

2006 Cartier, J., Farabee, D., & Prendergast, M.L. Methamphetamine use, violence, and recidivism among California parolees. Journal of Interpersonal Violence, 21, 435-445. (PMID: 16501213)

2007 Farabee, D., Knight, K., Garner, B., & Calhoun, S. The Inmate Pre-Release Assessment (IPASS) for re-entry planning. Criminal Justice & Behavior, 34(9), 1188-1197.

2007 Burdon, W.M., Dang, J., Prendergast, M. L., Messina, N.P., & Farabee, D. Differential effectiveness of residential versus outpatient aftercare for parolees from prison-based therapeutic community treatment programs. Substance Abuse Treatment, Prevention, and Policy, 2:16. (PMID: 17504540) (PMCID: PMC1884138)

2007 Grella, C.E., Greenwell, L., Prendergast, M.L., Farabee, D., Hall, E., Cartier, J., & Burdon, W. Organizational characteristics of drug abuse treatment programs for offenders. Journal of Substance Abuse Treatment, 32, 291-300. (PMID: 17383553) (PMCID: PMC1941644)

2009 Prendergast, M., Greenwell, L., Farabee, D., Hser, Y.I.., Influence of perceived coercion and motivation on treatment completion and re-arrest among substance-abusing offenders. J Behav Health Serv Res., 36(2), 159-76. (PMID: 18516684)

2010 Peng, E.Y., Lee, M., Morisky, D.E., Yeh, C.Y., Farabee, D., Lan, Y.C., Chen, Y.M.A., Lyu, S.Y. Psychiatric morbidity in HIV-infected male prisoners. Journal of the Formosan Medical Association, 109 (3), 177-184.

2010 Peng E.Y., Yeh C.Y., Lyu S.Y., Morisky D.E., Chen Y.M., Lee M.B., Farabee D., & Malow R. Prevalence and correlates of lifetime suicidal ideation among HIV-infected male inmates in Taiwan. AIDS Care, 10, 1212-1220. PMID: 20845113

2011 Farabee, D., Hawken, A., & Griffith, P. Tracking and incentivizing substance abusers in longitudinal research: Results of a survey of NIDA-funded investigators. Journal of Addiction Medicine, 5(2), 87-91. [PMC3140135]

2011 Farabee, D., Zhang, S.X., & Yang, J. A preliminary examination of offender needs assessment: Are all those questions really necessary? Journal of Psychoactive Drugs, 43, 1-7.

2012 Farabee, D. Zhang, S.X., & Wright, B. Managing an on-the-spot lottery in re-entry services. Journal of Experimental Criminology, 8,241–253.

2012 Karno, M., Farabee, D., Brecht, M.L., & Rawson, R.A. Patient reactance moderates the effect of directive telephone counseling for methamphetamine users. Journal of Studies on Alcohol and Drugs, 73, 844–850.

2012 Ling, W., Farabee, D., Liepa, D., & Wu, L. T. The Treatment Effectiveness Assessment (TEA): an efficient, patient-centered instrument for evaluating progress in recovery from addiction. Substance Abuse, 3, 129-136.

2012 Wright, B., Zhang, S.X., & Farabee, D. A squandered opportunity: A review of SAMHSA’s National Registry of Evidence-based Programs and Practices (NREPP) for offenders. Crime & Delinquency, 6, 954 – 972.

2013 Farabee, D, Cousins, S.J., Brecht, M.L., Antonini, V.P., Lee, A.B., Brummer, J., Hemberg, J., Karno, M., & Rawson, R.A. A Comparison of four telephone-based counseling styles for recovering stimulant users. Psychology of Addictive Behavior, 27.1, 223. (PMCID: PMC3500433, NIHMSID: NIHMS396172)

2013 Farabee, D., McCann, M., Brecht, M.L., Cousins, S.J., Antonini, V.P., Lee, A.B., Brummer, J., Hemberg, J., Karno, M. & Rawson, R.A. An analysis of relapse prevention factors and their ability to predict sustained abstinence following treatment completion. American Journal of Addictions, 22(3), 206-211.

2014 Lyu, S.Y., Chi.,Y.C., Farabee,. D., Tsai, L.T., Lee, M.B., Lo, F.E., & Morisky, D.E. Psychological distress in an incarcerated juvenile population. Journal of the Formosan Medical Association.

2014 Wright, B., Zhang, S.X., & Farabee, D. Prisoner reentry research from 2000-2010: Results of a narrative review. Criminal Justice Review, 39(1), 37-57.

2014 Zhang, S.X., Roberts, R., and Farabee, D. An analysis of prisoner reentry and parole risk using COMPAS and traditional criminal history measures. Crime & Delinquency, 60(2), 167-192.

In press Farabee, D., Calhoun, S., & Veliz, R. An experimental comparison of telepsychiatry and onsite psychiatry for parolees. Psychiatric Services.
Research Papers—Non-Peer Reviewed

1998 Lehman, W.E.K., Farabee, D, & Bennett, J.B. Perceptions and correlates of coworker substance abuse. Employee Assistance Quarterly, 13(4), 1-22.

2006 Farabee, D. An evaluation of California’s Mental Health Services Continumm Program for parolees. Corrections Today, 68(7), 38-41.

2015 Farabee, D. Book Review: The methamphetamine industry in America: Transnational cartels and local entrepreneurs. Criminal Justice Review, 0734016815573305.

2001 Farabee, D. and Leukefeld, C.G. Recovery and the criminal justice system. In J.J. Platt, F.M. Tims, and C.G. Leukefeld (Eds.) Relapse and Recovery Processes in the Addictions, pp. 40-59. New Haven, CT: Yale University

2002 Farabee, D. & Leukefeld, C.G. HIV/AIDS in the criminal justice system. In C.G. Leukefeld, F. Tims, and D. Farabee (Eds.) Treatment of Drug Offenders: Policies and Issues, pp. 172-185. New York: Springer.

2004 Farabee. D., Shen, H., Prendergast, M.L, & Cartier, J. The effectiveness of coerced admission into prison-based drug treatment. In K. Knight and D. Farabee (Eds.), Treating Addicted Offenders: A Continuum of Opportunities, pp. 31:1-12. New York: Civic Research Institute.

2004 Longshore, D., Prendergast, M., & Farabee, D. Coerced treatment for drug-using criminal offenders. In P. Bean (Ed.), Drug Treatment: What Works?, pp. 110-122. London: Taylor & Francis Books.

2005 Satel, S., & Farabee, D. The role of coercion in drug treatment. In J.H. Lowinson, P. Ruiz, R.B. Millman, & J.G. Langrod (Eds.) Substance Abuse: A Comprehensive Textbook, pp. 690-707. New York: Lippincott Williams & Wilkins.

2006 Messina, N., Farabee, D., & Rawson, R. Cocaine-dependent patients with antisocial personality disorder (Chapter 5). In F. Columbus (Ed.) Cocaine Abuse: New Research. Hauppauge, NY: Nova Science Publishers, Inc.

2007 Farabee, D. Monitoring drug use and medication adherence among mentally ill parolees. In K. Knight and D. Farabee (Eds.), Treating Addicted Offenders: A Continuum of Opportunities, Vol. II, pp. 20:1-3. New York: Civic Research Institute.

2009 Farabee, D., & Hawken, A. Methamphetamine and crime. In J. M. Roll, R. Rawson, W. Ling, & S. Shoptaw (Eds.). Methamphetamine Addiction. pp. 157-151. New York: Guilford.

2015 Farabee, D., Rawson, R.A., & Gawad, T. Treatment in the criminal justice system. In Nady El-Guebaly, Marc Galanter and Giuseppe Carrá (Eds), Textbook of Addiction Treatment: International Perspectives. Heidelberg, Germany: Springer.

2002 Farabee, D. Addicted to treatment: Ideology is trumping science in our quest to rehabilitate offenders. Forbes, December 23. p.60.

2002 Farabee, D., Prendergast, M.L., & Cartier, J. Alcohol, the “un-drug.” Psychiatric Services, 53 (11), 1375-1376. (PMID: 12407261)

2006 Farabee, D. Why the expansion of offender programs is premature. Journal of Community Corrections, 16(1), 9-10.

2006 Farabee, D. Reinventing criminal justice. Washington Post, February 11, . p A19.

2006 Farabee, D. Naltrexone as negative reinforcement: Comments on "A behavioral analysis of coercion in substance abuse treatment." Journal of Substance Abuse Treatment, 31(2), 141-142. (PMID: 17504540)

2007 Farabee, D. For the Second Chance Act of 2007, great strides will come in small steps. Federal Sentencing Reporter, 20 (2), 136-137.

Books

2002 Leukefeld, C.G., Tims, D., & Farabee, D. (Eds.) Treatment of Drug Offenders: Policies and Issues.New York: Springer.

2004 Knight, K. & Farabee, D. (Eds.), Treating Addicted Offenders: A Continuum of Opportunities. New York: Civic Research Institute.

2005 Farabee, D. Rethinking Rehabilitation: Why Can’t We Reform Our Criminals? Washington, DC: AEI Press.